↓ Skip to main content

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma

Overview of attention for article published in Journal of Translational Medicine, December 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
1 X user
patent
2 patents
f1000
1 research highlight platform

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
19 Mendeley